Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Walnut allergens are a group of proteins found in the seeds of the walnut tree, primarily Juglans regia (English walnut) and Juglans nigra (Black walnut), that are responsible for triggering IgE-mediated allergic reactions in sensitized individuals [2, 4]. These allergens belong to several distinct protein families, including seed storage proteins such as 2S albumins (Jug r 1), 7S vicilins (Jug r 2, Jug r 6), and 11S legumins (Jug r 4), as well as non-specific lipid transfer proteins (Jug r 3) and profilins (Jug r 5, Jug r 7) [3, 14]. Their biological functions in the plant include nutrient storage for embryo development, lipid transport, and defense against environmental stress or pathogens [6, 11]. In humans, these proteins act as potent antigens that induce the production of allergen-specific IgE antibodies; upon re-exposure, the cross-linking of these antibodies on mast cells and basophils triggers the release of inflammatory mediators [4, 7]. This immune response can lead to clinical symptoms ranging from mild oral allergy syndrome to life-threatening anaphylaxis [2, 6]. While there are currently no approved drugs that directly bind to and neutralize the allergen proteins themselves, therapeutic management involves the use of epinephrine for acute reactions and anti-IgE therapies like omalizumab to increase the threshold of reactivity [10, 20]. Additionally, walnut allergenic extracts are utilized in oral immunotherapy (OIT) to induce clinical desensitization and improve tolerance in allergic individuals [8, 10].
Adrenergic receptor agonism; IgE neutralization; IL-4/IL-13 signaling inhibition; Allergen-specific immunotherapy
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Walnut allergen.